An innovative, green, integrated pharmaceutical manufacturer established in 2020, specializing in pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and oral solid dosage forms. Located at No. 9 Jingshisan Road, Hangzhou Bay Economic and Technological Development Zone, Shangyu District, Shaoxing City, Zhejiang Province, it covers an area of nearly 100 acres with a building area of approximately 80,000 square meters. The facility includes eight API production workshops, each spanning 6,000m²; capable of installing nearly 400 various types of reaction vessels with a total reaction volume of about 2,000 cubic meters; one multifunctional API pilot workshop; one four-story oral solid dosage workshop of 8,000m², with an annual production capacity of up to 5 billion oral tablets and capsules; one comprehensive solid warehouse of 9,000m² and one Class A material warehouse of over 700m², among others. The factory is permitted to conduct a comprehensive range of reaction categories, including substitution, condensation, oxidation, catalytic hydrogenation, chlorination, amination, and more, and is also certified to handle highly toxic chemicals. It features an 850m² R&D building and a 1,700m² quality management building, with QC equipped with comprehensive analytical and testing instruments such as HPLC, GC, IR, UV, and others.